跳至主要内容
临床试验/NCT05819229
NCT05819229招募中不适用

Oral Antibiotics Alone in Children Aged 4 Weeks to 2 Months With a Suspected or Confirmed Uncomplicated Urinary Tract Infection. A Single-arm Multicenter Prospective Observational Study.

Rigshospitalet, Denmark4 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2023年2月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
125
试验地点
4
主要终点
Number of days admitted related to urinary tract symptoms

研究概览

简要总结

The goal of this prospective study is to investigate whether oral antibiotic therapy alone is feasible and safe in clinically stable children aged 4 weeks to 2 months without any past high-risk medical history with a suspected or confirmed urinary tract infection.

详细描述

All children aged 4 weeks to 2 months with a suspected urinary tract infection will be observed and examined by physicians and nurses as recommended by current guidelines. Children needing empirical antibiotic therapy will be admitted. The remaining will be contacted by phone if the urine culture is positive, and antibiotic therapy will be initiated if a urinary tract infection is still suspected due to persistent symptoms.

Clinically stable (see eligibility criteria) children without any past high-risk medical history (see eligibility criteria) will initiate oral antibiotic therapy. As empirical oral therapy, amoxicillin-clavulanic acid 50 mg/kg/day divided into 3 doses will be used. If the sensitivity pattern is available, a smaller-spectrum antibiotic can be used instead. If these children at any time point become clinically unstable or have a positive blood culture without suspected contamination, parenteral antibiotic therapy will be initiated. As empirical parenteral therapy, gentamicin 5 mg/kg once daily and ampicillin 100 mg/kg/day divided into 3 doses will be used. If the sensitivity pattern is available, another parenteral antibiotic regime can be used instead.

Admitted children can be sent home when they have clinically improved (judged by the physician) and have been hospitalized at least until the ward round the following day. Parents will be informed to contact the pediatric emergency department immediately if the child worsens or does not tolerate the antibiotics.

A physical or virtual follow-up will be conducted on day 3 (approximately 72 hours after treatment initiation) to ensure clinical improvement and treatment adherence. If needed, antibiotic therapy will be changed according to the sensitivity pattern. Children with a negative urine culture will be informed to stop antibiotic therapy.

The duration of antibiotic therapy will be 10 days. All children will undergo a renal ultrasound within the treatment period.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
4 Weeks 至 2 Months(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Oral antibiotic therapy

Clinically stable (see eligibility criteria) children without any past high-risk medical history (see eligibility criteria) will initiate oral antibiotic therapy.

干预措施: Oral antibiotic therapy (Drug)

结局指标

主要结局

Number of days admitted related to urinary tract symptoms

时间窗: Within 28 days after treatment initiation

Proportion of participants with recurrent urinary tract infection regardless of the pathogen or death of any cause

时间窗: Within 28 days after end of treatment

次要结局

  • Proportion of participants with a recurrent urinary tract infection regardless of the pathogen or death of any cause.(Within 100 days after end of treatment)
  • Number of days with antibiotic-related non-serious adverse events.(From date of treatment initiation until the date of treatment stop for the baseline infection, assessed up to 14 days)
  • Proportion of participants with a recurrent infection with a bacterium resistant to the antibiotic given for the baseline infection or an opportunistic infection(Within 100 days after end of treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ulrikka Nygaard

Principal investigator

Rigshospitalet, Denmark

研究点 (4)

Loading locations...

相似试验